Clinical development of RET inhibitors in RET-rearranged non-small cell lung cancer: Update

Luis Mendoza1

  • 1IQVIA, Prague, Czech Republic.

Oncology Reviews
|August 11, 2018
PubMed

Insights

Precision oncology, standard for advanced non-small cell lung cancer (NSCLC), identifies actionable RET rearrangements. While current RET inhibitors show benefit, more potent drugs are needed for RET-associated NSCLC.

Area of Science:

  • Oncology
  • Molecular Diagnostics
  • Pharmacology

Background:

  • Precision oncology is the standard for advanced non-small cell lung cancer (NSCLC).
  • RET rearrangements are actionable driver oncogenes identified through molecular profiling.
  • Immunohistochemistry is insufficient for detecting RET alterations; FISH, RT-PCR, and NGS are complementary.

Purpose of the Study:

  • To review clinical data on RET inhibitors in RET-associated NSCLC.
  • To highlight the need for improved RET inhibitors.

Main Methods:

  • Review of clinical data on RET inhibitors.
  • Analysis of diagnostic tools for RET rearrangements.

Main Results:

  • Existing RET inhibitors (cabozantinib, vandetanib, lenvatinib) demonstrate clinical benefits in response and progression-free survival for NSCLC.
  • Clinical results with current RET inhibitors are not striking, indicating a need for enhanced therapies.

Conclusions:

  • RET rearrangements are important targets in NSCLC management.
  • Development of more selective and potent RET inhibitors is crucial for improving patient outcomes in RET-associated NSCLC.

Related Concept Videos

[3,3] Sigmatropic Rearrangement of 1,5-Dienes: Cope Rearrangement01:21

[3,3] Sigmatropic Rearrangement of 1,5-Dienes: Cope Rearrangement

The Cope rearrangement is classified as a [3,3] sigmatropic shift in 1,5-dienes, leading to a more stable, isomeric 1,5-diene. The reaction involves a concerted movement of six electrons, four from two π bonds and two from a σ bond, via an energetically favorable chair-like transition state.
3.4K
[3,3] Sigmatropic Rearrangement of Allyl Vinyl Ethers: Claisen Rearrangement01:24

[3,3] Sigmatropic Rearrangement of Allyl Vinyl Ethers: Claisen Rearrangement

The Claisen rearrangement is a [3,3] sigmatropic rearrangement of allyl vinyl ethers to unsaturated carbonyl compounds. The rearrangement is a concerted pericyclic reaction proceeding via a chair-like transition state.
2.8K
Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
11.0K
Preparation of Diols and Pinacol Rearrangement01:57

Preparation of Diols and Pinacol Rearrangement

Compounds bearing two hydroxyl groups are known as diols. When the hydroxyl groups are located on adjacent carbon atoms, the diols are called vicinal diols or glycols. Under acidic conditions, vicinal diols undergo a specific reaction called pinacol rearrangement.
The reaction begins with transferring a proton from the acid catalyst to one of the hydroxyl groups, producing an oxonium ion.
4.3K
Lung Capacity01:47

Lung Capacity

The air in the lungs is measured in volumes and capacities. Lung volume measures reflect the amount of air taken in, released, or left over after a lung function, like a single inhalation. Lung capacity measures are sums of two or more lung volume measures.
56.4K
Clinical Applications of Epidermal Stem Cells01:19

Clinical Applications of Epidermal Stem Cells

Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
3.3K